NASDAQ · KLACHealthcareOptical Instruments

KLA financials

$196.53+3.89%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY26
Jun 30
FY25
Jun 30
FY24
Jun 30
FY23
Jun 30
FY22
Jun 30
FY21
Jun 30
FY20
Jun 30
FY19
Jun 30
FY18
Jun 30
FY17
Jun 30
Revenue$13.58B$12.16B$9.81B$10.50B$9.21B$6.92B$5.81B$4.57B$4.04B$3.48B
Gross profit$8.32B$7.40B$5.88B$6.28B$5.62B$4.15B$3.36B$2.70B$2.59B$2.19B
Gross margin61.3%60.9%60.0%59.8%61.0%59.9%57.8%59.1%64.2%63.0%
Operating income$5.66B$4.78B$3.35B$3.99B$3.65B$2.49B$1.50B$1.39B$1.54B$1.28B
Net income$4.83B$4.06B$2.76B$3.39B$3.32B$2.08B$1.22B$1.18B$802.3M$926.1M
Net margin35.6%33.4%28.1%32.3%36.1%30.0%21.0%25.7%19.9%26.6%
Diluted EPS$3.66$3.04$2.03$2.42$2.19$1.34$0.77$0.75$0.51$0.59
EBITDA$6.05B$5.41B$4.04B$4.41B$4.02B$2.82B$2.11B$1.62B$1.60B$1.34B
Operating cash flow$4.14B$4.08B$3.31B$3.67B$3.31B$2.19B$1.78B$1.15B$1.23B$1.08B
Free cash flow$3.77B$3.75B$3.03B$3.33B$3.01B$1.95B$1.63B$1.02B$1.16B$1.04B
Diluted shares1,319.6M1,337.5M1,361.9M1,402.4M1,515.6M1,554.4M1,580.1M1,569.5M1,573.8M1,574.8M

Balance sheet

Period endJun 30Jun 30Jun 30Jun 30Jun 30Jun 30
Cash & equivalents$1.65B$2.08B$1.98B$1.93B$1.58B$1.43B
Short-term investments$3.25B$2.42B$2.53B$1.32B$1.12B$1.06B
Total debt$5.89B$5.88B$6.63B$5.89B$6.66B$3.44B
Total assets$17.95B$16.07B$15.43B$14.07B$12.60B$10.27B
Total liabilities$11.60B$11.38B$12.07B$11.15B$11.20B$6.90B
Shareholders' equity$6.35B$4.69B$3.37B$2.92B$1.40B$3.38B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology